Europe 3D Cell Culture Market Size, Share & Industry Trends Analysis Report By Type (Scaffold-based, Scaffold-free, Microfluidics-based, and Magnetic & Bioprinted), By Application, By End User, By Country and Growth Forecast, 2022 - 2028

Europe 3D Cell Culture Market Size, Share & Industry Trends Analysis Report By Type (Scaffold-based, Scaffold-free, Microfluidics-based, and Magnetic & Bioprinted), By Application, By End User, By Country and Growth Forecast, 2022 - 2028

The Europe 3D Cell Culture Market would witness market growth of 15.2% CAGR during the forecast period (2022-2028).

3D cell cultures are more stable as well as have extended lifespans in contrast to 2D cell cultures. This indicates that they are better ideal for long-term trials and demonstrating the drug's long-term effects. Additionally, 3D surroundings allow cells to grow undisturbed. In 2D, cells must be regularly trypsinized in order to receive enough nutrients for optimal cell development.

Three-dimensional spheroids have been cultivated in the laboratory for up to 302 days while sustaining healthy, noncancerous development. Preclinical testing of the pharmacokinetic and pharmacodynamic effects of medicines and nanomaterials is the main objective of growing cells in 3D scaffolds and also as 3D cell spheroids in vitro.

Toxicology studies have demonstrated that 3D cell cultures are comparable to in vivo studies for assessing the toxicity of medicinal molecules. When comparing LD50 values for six common medications, diclofenac, acetaminophen, amiodarone, metformin, phenformin, and valproic acid, 3D spheroid values correlated directly with in vivo study values.

The industry of research and development in European nations is substantial. Europe comprises 21 OECD countries that are also members of the European Union, as well as Iceland, Norway, and Switzerland, according to the Organization for Economic Co-operation and Development Library. The government's funding for research and development, or GBARD, encompasses both the government's direct R&D and the sums allocated to other institutions for R&D.

The Germany market dominated the Europe 3D Cell Culture Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $212.4 million by 2028. The UK market is anticipated to grow at a CAGR of 14.3% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 16% during (2022 - 2028).

Based on Type, the market is segmented into Scaffold-based, Scaffold-free, Microfluidics-based, and Magnetic & Bioprinted. Based on Application, the market is segmented into Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing, and Tissue Engineering & Regenerative Medicine. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Research Institutes, Cosmetic Industry, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Merck Group, Avantor, Inc., Corning Incorporated, Lonza Group AG, Mimetas B.V., Insphero AG, Emulate, Inc., Tecan Group Ltd., and CN Bio Innovations Ltd.

Scope of the Study

Market Segments covered in the Report:

By Type

  • Scaffold-based
  • Scaffold-free
  • Microfluidics-based
  • Magnetic & Bioprinted
By Application
  • Cancer & Stem Cell Research
  • Drug Discovery & Toxicology Testing
  • Tissue Engineering & Regenerative Medicine
By End User
  • Pharmaceutical & Biotechnology Companies
  • Research Institutes
  • Cosmetic Industry
  • Others
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • Thermo Fisher Scientific, Inc.
  • Merck Group
  • Avantor, Inc.
  • Corning Incorporated
  • Lonza Group AG
  • Mimetas B.V.
  • Insphero AG
  • Emulate, Inc.
  • Tecan Group Ltd.
  • CN Bio Innovations Ltd.
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe 3D Cell Culture Market, by Type
1.4.2 Europe 3D Cell Culture Market, by Application
1.4.3 Europe 3D Cell Culture Market, by End User
1.4.4 Europe 3D Cell Culture Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansion
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2018, May – 2022, Oct) Leading Players
3.3.3 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2020, Jun – 2022, Jun) Leading Players
Chapter 4. Europe 3D Cell Culture Market by Type
4.1 Europe Scaffold-based Market by Country
4.2 Europe Scaffold-free Market by Country
4.3 Europe Microfluidics-based Market by Country
4.4 Europe Magnetic & Bioprinted Market by Country
Chapter 5. Europe 3D Cell Culture Market by Application
5.1 Europe Cancer & Stem Cell Research Market by Country
5.2 Europe Drug Discovery & Toxicology Testing Market by Country
5.3 Europe Tissue Engineering & Regenerative Medicine Market by Country
Chapter 6. Europe 3D Cell Culture Market by End User
6.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
6.2 Europe Research Institutes Market by Country
6.3 Europe Cosmetic Industry Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe 3D Cell Culture Market by Country
7.1 Germany 3D Cell Culture Market
7.1.1 Germany 3D Cell Culture Market by Type
7.1.2 Germany 3D Cell Culture Market by Application
7.1.3 Germany 3D Cell Culture Market by End User
7.2 UK 3D Cell Culture Market
7.2.1 UK 3D Cell Culture Market by Type
7.2.2 UK 3D Cell Culture Market by Application
7.2.3 UK 3D Cell Culture Market by End User
7.3 France 3D Cell Culture Market
7.3.1 France 3D Cell Culture Market by Type
7.3.2 France 3D Cell Culture Market by Application
7.3.3 France 3D Cell Culture Market by End User
7.4 Russia 3D Cell Culture Market
7.4.1 Russia 3D Cell Culture Market by Type
7.4.2 Russia 3D Cell Culture Market by Application
7.4.3 Russia 3D Cell Culture Market by End User
7.5 Spain 3D Cell Culture Market
7.5.1 Spain 3D Cell Culture Market by Type
7.5.2 Spain 3D Cell Culture Market by Application
7.5.3 Spain 3D Cell Culture Market by End User
7.6 Italy 3D Cell Culture Market
7.6.1 Italy 3D Cell Culture Market by Type
7.6.2 Italy 3D Cell Culture Market by Application
7.6.3 Italy 3D Cell Culture Market by End User
7.7 Rest of Europe 3D Cell Culture Market
7.7.1 Rest of Europe 3D Cell Culture Market by Type
7.7.2 Rest of Europe 3D Cell Culture Market by Application
7.7.3 Rest of Europe 3D Cell Culture Market by End User
Chapter 8. Company Profiles
8.1 Thermo Fisher Scientific, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.1.5.2 Acquisition and Mergers:
8.1.5.3 Geographical Expansions:
8.2 Merck Group
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 Avantor, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Recent strategies and developments:
8.3.4.1 Partnerships, Collaborations, and Agreements:
8.3.4.2 Acquisition and Mergers:
8.4 Corning Incorporated
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.5 Lonza Group AG
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Geographical Expansions:
8.6 Mimetas B.V.
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Product Launches and Product Expansions:
8.7 Insphero AG
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Partnerships, Collaborations, and Agreements:
8.7.2.2 Product Launches and Product Expansions:
8.8 Emulate, Inc.
8.8.1 Company Overview
8.9 Tecan Group Ltd.
8.9.1 Company Overview
8.10. CN Bio Innovations Ltd.
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Product Launches and Product Expansions:
8.10.2.3 Geographical Expansions:

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings